Vancomycin-Resistant Enterococcal Bacteremia in a Hematology Unit: Risk Factors for Mortality and Impact of Adequate Antimicrobial Therapy on Mortality

참고문헌 (40)

1. Leclercq R, "Plasmid-mediated resistance to vancomycin and teicoplanin in enterococcus faecium", 319, pp.157~61 (1988)
2. Uttley AH, "Vancomycin-resistant enterococci", 1, pp.57~58 (1988)
3. Edmond MB, "Vancomycin- resistant enterococcus faecium bacteremia:Risk factors for infection", 20, pp.1126~1133 (1995)
4. McNeil SA, "Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients:A prospective surveillance study", 42, pp.195~203 (2006)
5. Achenbach C, "Prevalence of and risk factors for colonization with vancomycin-resistant enterococcus among human immunodeficiency virus-positive outpatients", 27, pp.102~104 (2006)
6. Kapur D, "Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation", 25, pp.147~152 (2000)
7. Avery R, "Early vancomycin-resistant enterococcus (vre) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course", 35, pp.497~499 (2005)
8. Dubberke ER, "Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: Are the sick getting sicker?", 38, pp.813~819 (2006)
9. Shay DK, "Epidemiology and mortality risk of vancomycin- resistant enterococcal bloodstream infections", 172, pp.993~1000 (1995)
10. Lautenbach E, "Enterococcal bacteremia:Risk factors for vancomycin resistance and predictors of mortality", 20, pp.318~323 (1999)
11. Stroud L, "Risk factors for mortality associated with enterococcal bloodstream infections", 17, pp.576~580 (1996)
12. Linden PK, "Effect of quinupristin", dalfopristin on the outcome of vancomycin-resistant enterococcus faecium bacteraemia:Comparison with a control cohort, 1997, 145~151
13. Knaus WA, "Apache ii:A severity of disease classification system", 13, pp.818~29 (1985)
14. Bone RC, "The accp-sccm consensus conference on sepsis and organ failure", 101, pp.1481~3 (1992)
15. Rangel-Frausto MS, "The natural history of the systemic inflammatory response syndrome (sirs)", 273, pp.117~123 (1995)
16. NCCLS, "Performance standards for antimicrobial susceptibility testing:Ninth information supplement m100-s9" (1999), NCCLS
17. DiazGranados CA, "Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection", 191, pp.588~595 (2005)
18. Dougherty SH, "Role of enterococcus in intraabdominal sepsis", 148, pp.308~12 (1984)
19. Bartlett JG, "A review.Lessons from an animal model of intra-abdominal sepsis", 113, pp.853~7 (1978)
20. Hoffmann SA, "Putting the bug in our ears", pp.757~61 (1987)
21. Linden PK, "Vancomycin-resistant enterococci:The clinical effect of a common nosocomial pathogen", 33, pp.113~120 (1999)
22. Gullberg RM, "Enterococcal bacteremia:Analysis of 75 episodes", 11, pp.74~85 (1989)
23. Barrall DT, "Enterococcal bacteremia in surgical patients", 120, pp.57~63 (1985)
24. Garnacho-Montero J, "Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis", 31, pp.2742~2751 (2003)
25. Kollef MH, "Inadequate antimicrobial treatment of infections:a risk factor for hospital mortality among critically ill patients", 115, pp.462~474 (1999)
26. Pittet D, "Bedside prediction of mortality from bacteremic sepsis.A dynamic analysis of ICU patients", 152, pp.684~693 (1996)
27. Valles J, "Community-acquired bloodstream infection in critically ill adult patients:impact of shock and appropriate antibiotic therapy on survival", 123, pp.1615~1624 (2003)
28. Clec'h C, "Efficacy of adequate early antibiotic therapy in ventilator- associated pneumonia: influence of disease severity", 30, pp.1327~1333 (2004)
29. Malone DA, "Enterococcal bacteremia in two large community teaching hospitals", 81, pp.601~6 (1986)
30. Hoge CW, "To treat or not to treat", pp.600~5 (1991)
31. Venditti M, "Enterococcal septicemia in patients with hematological malignancies", 12, pp.241~7 (1993)
32. Maki DG, "the risk of endocarditis", pp.248~69 (1988)
33. Pallares R, "Cephalosporins as risk factor for nosocomial enterococcus faecalis bacteremia.A matched case-control study", 153, pp.1581~6 (1993)
34. Ostrowsky BE, "Vancomycin-resistant enterococci in intensive care units:High frequency of stool carriage during a non-outbreak period", 159, pp.1467~1472 (1999)
35. Hughes WT, "2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer", 34, pp.730~751 (2002)
36. Hershberger E, "Quinupristin-dalfopristin resistance in gram-positive bacteria:Mechanism of resistance and epidemiology", 38, pp.92~98 (2004)
37. Gray J, "Enterococcal bacteremia:a prospective study of 125 episodes", 27, pp.179~86 (1994)
38. Mohanty S, "Enterococcal bacteremia in a tertiary care hospital of North India", 103, pp.31~37 (2005)
39. Shaked H, "Enterococcal bacteremia: Epidemiological, microbiological, clinical and prognostic characteristics, and the impact of high level gentamicin resistance", 38, pp.995~1000 (2006)
40. Perencevich EN, "Excess shock and mortality in staphylococcus aureus related to methicillin resistance", 31, pp.1311~1313 (2000)

관련 논문AI추천